Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Clinical Rx -
datumbeskrivningstorlekförfattare dokument 
04.12.12SirT1 mediated modulation of circulating cytokines in Huntington’s Disease - pharmacodynamics results from Phase 1b study of Selisistat - a SirT1 inhibitor1.1 MBblankinapplication/pdf
04.12.12A randomized, double-blind, placebo-controlled Phase Ib pharmacodynamic study with Selisistat (SEN0014196) in HD patients928 kBblankinapplication/pdf
04.12.12Effects of Tetrabenazine on choreiform movements in the ransgenic rat model of Huntington’s Disease1009 kBblankinapplication/pdf
04.12.12Impact of Tetrabenazine on balance and gait in individuals with Huntington’s Disease996 kBblankinapplication/pdf
04.12.12Adverse effects of antipsychotics and antidepressants in advanced HD: four cases in a skilled nursing facility872 kBblankinapplication/pdf
04.12.12Multivariate classification of central nervous system-acting drugs based on in vivo response patterns – profile of pridopidine1015 kBblankinapplication/pdf
04.12.12Long-term safety and tolerability of pridopidine in patients with Huntington’s Disease (HD): results of the MermaiHD study open-label extension1.1 MBblankinapplication/pdf
04.12.12Potential neuroprotective effects of pridopidine in Huntington’s Disease1010 kBblankinapplication/pdf
04.12.12Valproic Acid for the treatment of aggressiveness in Huntington’s disease: one year follow-up827 kBblankinapplication/pdf
04.12.12ACTION-HD: A randomized, double-blind, placebo-controlled prospective crossover trial investigating the efficacy and safety of bupropion in Huntington’s Disease972 kBblankinapplication/pdf
04.12.12A randomised feasibility study of a 12-week exercise programme in Huntington’s disease (HD)1.1 MBblankinapplication/pdf
04.12.12Perspectives of participating in a 12 week exercise programme for people with early -mid stage Huntington's Disease1.1 MBblankinapplication/pdf
04.12.12Sub maximal exercise testing in people with early stage Huntington's Disease1.1 MBblankinapplication/pdf
04.12.12A pilot study of an exercise intervention to improve motor function in people with Huntington’s disease (HD)1.0 MBblankinapplication/pdf
04.12.12Exercises for self-perception as an alternative type of physiotherapeutic practice increase motivation for other therapeutic interventions in HD1.2 MBblankinapplication/pdf
04.12.12Psychomotor therapy and the training of relaxation skills in dealing with chorea and stress897 kBblankinapplication/pdf
04.12.12Music therapy as a method to improve the quality of life of patients with Huntington’s Disease – preliminary findings1.0 MBblankinapplication/pdf
04.12.12Intensive rehabilitation for Huntington's Disease: a qualitative study of participants' and health professionals' experiences1.1 MBblankinapplication/pdf
04.12.12A multidisciplinary intensive rehabilitation program for persons with Huntington's Disease: Results after one year1005 kBblankinapplication/pdf
04.12.12A rehabilitation centers multidisciplinary approach to treatment of HD-patients983 kBblankinapplication/pdf
04.12.12Study of the suitability of a garden for use by clients with Huntington's Disease, relatives and staff for therapy and leisure gardening1.2 MBblankinapplication/pdf

Mapp innehåller 21 dokument.